• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲荆豆I凝集素作为人体组织中血管内皮的标志物

Ulex europaeus I lectin as a marker for vascular endothelium in human tissues.

作者信息

Holthöfer H, Virtanen I, Kariniemi A L, Hormia M, Linder E, Miettinen A

出版信息

Lab Invest. 1982 Jul;47(1):60-6.

PMID:6177923
Abstract

Ulex europaeus I agglutinin, a lectin specific for some alpha-L-fucose-containing glycocompounds, was used in fluorescence microscopy to stain cryostat sections of human tissues. The endothelium of vessels of all sizes was stained ubiquitously in all tissues studied as judged by double staining with a known endothelial marker, antibodies against human clotting factor VIII. Cultured human umbilical vein endothelial cells, but not fibroblasts, also bound Ulex lectin. The staining was not affected by the blood group type of the tissue donor. In some tissues Ulex lectin presented additional binding to epithelial structures. Also, this was independent on the blood group or the ability of the tissue donor to secrete soluble blood group substances. Lotus tetragonolobus agglutinin, another lectin specific for some alpha-L-fucose-containing moieties failed to react with endothelial cells. Our results suggest that Ulex europaeus I agglutinin is a good histologic marker for endothelium in human tissues.

摘要

欧洲荆豆凝集素I是一种对某些含α-L-岩藻糖的糖化合物具有特异性的凝集素,在荧光显微镜检查中用于对人体组织的低温切片进行染色。通过与已知的内皮标记物——抗人凝血因子VIII抗体进行双重染色判断,在所有研究的组织中,各种大小血管的内皮均被普遍染色。培养的人脐静脉内皮细胞能结合荆豆凝集素,而成纤维细胞则不能。染色不受组织供体血型的影响。在一些组织中,荆豆凝集素与上皮结构有额外的结合。同样,这也与血型或组织供体分泌可溶性血型物质的能力无关。另一种对某些含α-L-岩藻糖部分具有特异性的凝集素——四角豆凝集素,未能与内皮细胞发生反应。我们的结果表明,欧洲荆豆凝集素I是人体组织内皮的良好组织学标记物。

相似文献

1
Ulex europaeus I lectin as a marker for vascular endothelium in human tissues.欧洲荆豆I凝集素作为人体组织中血管内皮的标志物
Lab Invest. 1982 Jul;47(1):60-6.
2
Lectin binding in the anterior segment of the bovine eye.凝集素在牛眼前节中的结合
Histochem J. 1994 Oct;26(10):787-98.
3
Studies of the endothelial origin of cells in systemic angioendotheliomatosis and other vascular lesions of the brain and meninges using ulex europaeus lectin stains.利用荆豆凝集素染色法对系统性血管内皮瘤病及脑和脑膜其他血管病变中细胞的内皮起源进行研究。
Clin Neuropathol. 1986 Nov-Dec;5(6):231-7.
4
Comparison of Ulex europaeus I lectin and factor VIII-related antigen in vascular lesions.欧洲荆豆I凝集素与血管病变中VIII因子相关抗原的比较。
Arch Pathol Lab Med. 1984 Feb;108(2):129-32.
5
Endothelial cell markers in vascular neoplasms: an immunohistochemical study comparing factor VIII-related antigen, blood group specific antigens, 6-keto-PGF1 alpha, and Ulex europaeus 1 lectin.血管肿瘤中的内皮细胞标志物:一项比较因子VIII相关抗原、血型特异性抗原、6-酮-前列腺素F1α和欧洲荆豆1凝集素的免疫组织化学研究
J Pathol. 1986 Jun;149(2):89-95. doi: 10.1002/path.1711490203.
6
Distribution of fucosubstance in kidney and related neoplasms. Absence of lectin-reactive alpha-fucose from the vasculature of bilateral Wilm's tumors.岩藻糖物质在肾脏及相关肿瘤中的分布。双侧肾母细胞瘤血管中缺乏凝集素反应性α-岩藻糖。
Arch Pathol Lab Med. 1988 Sep;112(9):908-13.
7
The failure of renal vascular endothelium from paraffin sections to stain with peroxidase conjugated Ulex europaeus I (UEA I) lectin.石蜡切片中肾血管内皮未能被过氧化物酶偶联荆豆凝集素I(UEA I)染色。
Lab Invest. 1983 Mar;48(3):363-5.
8
[Immunoperoxidase labelling of blood vessels by 3 lectins: Ulex europaeus I, Lotus tetragonolobus, Dolichos biflorus].[三种凝集素对血管的免疫过氧化物酶标记:欧洲荆豆凝集素I、四角豆凝集素、双花扁豆凝集素]
C R Seances Soc Biol Fil. 1985;179(1):59-69.
9
Intravital lectin perfusion analysis of vascular permeability in human micro- and macro- blood vessels.人体微血管和大血管血管通透性的活体凝集素灌注分析
Histochem Cell Biol. 2001 Oct;116(4):349-59. doi: 10.1007/s004180100328.
10
Monoclonal antibody PAL-E specific for endothelium.针对内皮细胞的单克隆抗体PAL-E。
Lab Invest. 1985 Jan;52(1):71-6.

引用本文的文献

1
Angiosarcoma: a systematic review of biomarkers in diagnosis, prognosis, and therapeutic strategies.血管肉瘤:关于诊断、预后及治疗策略中生物标志物的系统综述
Front Oncol. 2025 Jul 1;15:1623327. doi: 10.3389/fonc.2025.1623327. eCollection 2025.
2
Modulation of Estrogen Receptor Activity by the Phytoalexin Tuberosin Produced from Elicited Kudzu ().诱导的葛根产生的植物抗毒素块根素对雌激素受体活性的调节作用
J Nat Prod. 2025 Jul 25;88(7):1568-1580. doi: 10.1021/acs.jnatprod.5c00192. Epub 2025 Jun 20.
3
Complement pathway activation mediates pancreatic cancer-induced muscle wasting and pathological remodeling.
补体途径激活介导胰腺癌诱导的肌肉萎缩和病理重塑。
J Clin Invest. 2025 Apr 8;135(12). doi: 10.1172/JCI178806. eCollection 2025 Jun 16.
4
Antitumor Activity, Mechanisms of Action and Phytochemical Profiling of Sub-Fractions Obtained from Planch. (Fabaceae): A Medicinal Plant from Galicia (Spain).从西班牙加利西亚的药用植物扁轴木(豆科)中获得的亚组分的抗肿瘤活性、作用机制及植物化学分析
Molecules. 2025 Feb 19;30(4):972. doi: 10.3390/molecules30040972.
5
A lectin produced by a Streptomyces species targets mammalian pancreatic acinar cells in mice and humans.一种由链霉菌属物种产生的凝集素作用于小鼠和人类的哺乳动物胰腺腺泡细胞。
Sci Rep. 2025 Jan 22;15(1):2782. doi: 10.1038/s41598-024-80889-y.
6
Adaptable Manufacturing and Biofabrication of Milliscale Organ Chips With Perfusable Vascular Beds.具有可灌注血管床的毫米级器官芯片的适应性制造与生物制造
Biotechnol J. 2024 Dec;19(12):e202400550. doi: 10.1002/biot.202400550.
7
Context-Dependent Estrogenic Actions of (+)-Pisatin Produced in Elicited Green or Snow Pea ().诱导产生的(+)-豌豆素在青豌豆或食荚豌豆中的情境依赖性雌激素作用
J Agric Food Chem. 2024 Dec 25;72(51):28255-28269. doi: 10.1021/acs.jafc.4c06409. Epub 2024 Dec 12.
8
Clinical, Dermoscopic, and Molecular Features of Acantholytic Squamous Cell Carcinoma: A Systematic Review.棘层松解性鳞状细胞癌的临床、皮肤镜及分子特征:一项系统评价
Cancers (Basel). 2024 Aug 21;16(16):2905. doi: 10.3390/cancers16162905.
9
Lectins As Effective Tools in the Study of the Biliary Network and the Parenchymal Architecture of the Zebrafish () Liver.凝集素作为研究斑马鱼肝脏胆管网络和实质结构的有效工具()。
Zebrafish. 2024 Apr;21(2):177-180. doi: 10.1089/zeb.2023.0073.
10
High-throughput Analysis of Capillary Density in Skeletal Muscle Cross Sections.骨骼肌横切面中毛细血管密度的高通量分析
Bio Protoc. 2024 Jan 20;14(2):e4922. doi: 10.21769/BioProtoc.4922.